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A total of 497 raw milk samples collected at individual farms and collection tanks for milk from eight regions from 
Macedonia were examined for chloramphenicol, sulfonamides, quinolones and tetracyclines from October 2008 
until April 2011. Immunoassay methods were used for the determination of chloramphenicol, sulfonamides and 
quinolones, and high performance liquid chromatography with Diode Array detection was applied for screening of 
tetracyclines. The methods were validated according to the recommendations laid down by European Commission 
Decision 2002/657/EC. The obtained data conﬁ  rmed that the methods were appropriate for detection of antibiotics 
determined, at the concentration level of interest. Measured range of concentrations (in μg/kg) was 13.5-147.9 
for sulfonamides, 0.6-22.0 for quinolones and 17.4-149.1 for tetracyclines, with calculated mean values (in μg/
kg) 24.7 for sulfonamides, 12.6 for qinolones and 41.9 for tetracyclines. None of the analyzed samples showed 
presence of chloramphenicol over the minimum required performance level value of the screening method. The 
calculated estimated daily intakes for the average daily consumption of 200 mL of milk for an adult in Macedonia, 
for the examined antimicrobials, obtained levels 2 to 100 times lower than the values of the acceptable daily 
intakes ﬁ  xed by World Health Organization. This indicates that toxicological risk associated with the consumption 
of analyzed milk could not be considered as a public health issue with regards to these veterinary drugs.
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ABSTRACT
INTRODUCTION
Antimicrobial agents are widely used at milk 
producing animals. Improper administration of the 
veterinary medicinal products (VMP) for disease 
therapy and growth promotion may result in 
presence of antimicrobial residues in milk and dairy 
products, and can contribute to the development of 
microbial drug resistance and the spread of resistant 
bacteria (1). Also, the residues of VMP present a 
potential risk to the consumer, particularly with the 
appearance of allergic reactions and interferences 
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of intestinal micro-ﬂ  ora (2). From the technological 
prospective, residues of antimicrobial agents in 
milk can cause signiﬁ   cant losses in fermented 
products, by inhibition of bacterial fermentation in 
the production processes of cheese or yoghourt (3).
Due to harmful effects of VMP residues, 
surveillance systems are enforced in the European 
Union related to the requirements laid down in the 
Council Directive 96/23/EC (4). According with 
these requirements, the Macedonian legislation was 
fully aligned with the EU legislation concerning 
residues of VMP in foodstuffs of animal origin in 6
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regarding the Council regulation 37/2010/EU (5). 
Therefore, accurate detection of low levels 
of antimicrobial drug residues in milk is of great 
importance for the diary industry and for farmers, 
with a purpose to ensure that the contaminated milk 
form individual cows are not consigned to the bulk 
tank (6). Consequently, it is necessary to monitor a 
large number of milk samples for the presence of 
the most important antimicrobial drug residues, 
by using rapid and reliable microbiological 
(7,8), immunological (9,10) or physico-chemical 
screening methods (11-13). All methods used for 
that purpose have to detect antibiotics at or below 
their permissible limits or MRLs and also have to be 
validated in accordance with the Council Directive 
2002/657/EC (14). 
Unlike the other countries from the region, the 
annual consumption of milk and diary products in 
Macedonia is somewhat lower, and for 2009 it was 
around 72 L per capita (15,16). In the last decades 
there were few studies about the screening of 
VMP residues in raw milk samples collected from 
Macedonia (17-19). In order to monitor veterinary 
drug contamination in milk samples from diary 
farms and individual production facilities, residual 
concentrations of chloramphenicol, sulfonamides, 
qinolones and tetracyclines were examined. 
Furthermore, an estimation of the dietary intake 
of veterinary drugs residues derived from milk 
consumption was performed.
MATERIALS AND METHODS
Sampling
A total of 497 raw milk samples were collected 
from October 2008 to April 2011 at individual 
small milk-producing facilities and from the 
collection tanks of milk routes in eight regions 
form Macedonia. Samples were stored at 4-8oC if 
analyzed within 24 hours after sampling, or kept at 
less than -20oC for four weeks.
Reagents and standard solutions
The Chloramphenicol ELISA kit (type AB630) 
and quinolones (enroﬂ  oxacin,  ciproﬂ  oxacin, 
norﬂ  oxacin,  danoﬂ   oxacin, oxolinic acid, 
ﬂ   umequine) ELISA kit (type AB630) were 
purchased by TECNA (Trieste, Italy). The Multi-
sulfonamides (sulfadimidine, sulfamerazine, 
sulfachloropyridazine, sulﬁ  soxazole,  sulfadiazine, 
sulfachloropyridazine, sulfametoxazole) ELISA kit 
(type 5101SULMp) was supplied from Europroxima 
(Arnhem, The Netherlands). Ethyl acetate, citric 
acid, disodium hydrogen phosphate, zink sulphate 
heptahydrate, potassium hexacyanoferrate (II) and 
oxalic acid were with p.a. purity, supplied from 
Merck (Darmstadt, Germany). Sodium EDTA was 
supplied by Sigma (St. Louis, USA). Methanol, 
acetonitrile and water were with HPLC grade, and 
were supplied from Sigma (St. Louis, USA).
The certiﬁ  ed pure neat standards of sulfadimidine, 
sulﬁ   soxazole, oxytetracycline hydrochloride, 
tetracycline hydrochloride, chlorotetracycline 
hydrochloride, doxycycline hyclate, enroﬂ  oxacin 
and chloramphenicol were supplied from Sigma-
Aldrich (St. Louis, USA). 
Standard solutions and spiking of samples
Standard stock solutions with concentration 
of 1 mg/mL were prepared on monthly basis by 
dissolving the analytes in methanol. Intermediate 
working solutions were prepared prior to usage 
by diluting tetracycline’s solutions in methanol, 
while sulfonamides, ﬂ  uoroquinolones  and 
chloramphenicol solutions were prepared in sample 
dilution buffers, provided in the EIA kits. These 
solutions were used for spiking blank milk samples 
at different levels. Following fortiﬁ  cation, samples 
were allowed to equilibrate for 15 minutes before 
extraction.
Instruments
For sample preparation vortex model Relax Top 
by Heidolph (Schwabach, Germany), centrifuge 
model 2K15 by Sigma (St. Louis, USA), evaporator 
model DriBlock DB-3D by TECHNE (Staffordshire, 
UK) were used. The optical density at 450 nm for the 
EIA tests was measured by microplate reader BDSL 
Immunoscan (Labsystem, Switzerland). Liquid 
chromatographic separation of the tetracyclines in 
isocratic mode was performed on reverse-phase C8 
Ascentis column, supplied by Supelco (Belafonte, 
USA). Applied mobile phase was a mixture of 0,01 
mol/dm3 oxalic acid, methanol and acetnitrile in 
ratio 70:20:20 (V/V/V). Detection of tetracyclines 
was performed on Perkin Elmer LC 235C diode 
array instrument (Norwalk, USA) at 365 nm.7
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Sample preparation for the screening methods
Sample preparation, as well as preparation of 
all reagents for chloramphenicol, sulfonamides and 
quinolones, was according to the manufacturer’s 
instructions. Milk samples for chloramphenicol and 
sulfonamides were prepared by defatting of samples 
by centrifugation at +4 oC and 3000 rpm, extraction 
with ethylacetate, and evaporation under the stream 
of nitrogen. The prepared samples were ﬁ  nally 
dissolved in sample dilution buffers, included in 
the EIA kits, and applied on the microtiter plates. 
For chloramphenicol the dilution factor was 0.1, 
while for sulfonamides it was 20. The milk samples 
for analysis of quinolones were deproteinized by 
adding Carrez I and Carrez II reagents, centrifuged 
and diluted with sample dilution buffer in ratio 1:9 
(tenfold dilution). 
Tetracyclines (oxytetracycline, tetracycline, 
chlorotetracycline and doxycycline) were determined 
by modiﬁ  ed and optimized screening reverse-phase 
High-performance liquid chromatography/diode 
array detector (HPLC/DAD) method (20), with 
previous extraction with McIlvaine buffer and 
puriﬁ  cation of the sample extracts on OASIS HLB 
solid-phase extraction cartridges (Waters, Milford, 
USA). The samples were ﬁ  nally dissolved in 0.01 
mol/dm3 oxalic acid buffer, ﬁ  ltered through 0.45 μm 
syringe ﬁ  lters and injected into the HLPC system. 
The dilution factor was 0.2. 
Validation of the screening methods
Performance characteristics of EIA methods and 
the screening HPLC-DAD method were determined 
as prescribed for qualitative screening methods in 
Commission Decision 2002/657/EC (14). Also the 
limit of detection (LOD) and limit of quantiﬁ  cation 
(LOQ) were obtained by adding 3 and 10 times 
the standard deviation of 20 blank samples to 
the mean blank value. Recovery was assessed 
by performing the experiments where fortiﬁ  ed 
milk samples were analyzed in ten replicates, at 
the respective maximum residue level (MRL) or 
minimum required performance level (MRPL) 
values for the substances being analyzed. From the 
recovery experiments the method precision was 
obtained, as well. The detection capability (CCβ) 
for tetracyclines, quinolones and sulfonamides 
was determined by spiking of 20 blank samples 
at the one half of the MRL value set at 100 μg/kg 
(5), while for chloramphenicol the spiking level 
was below the established MRPL value of 0,3 μg/
kg (21). The calculations were performed by the 
formula provided in the EU Commission Decision 
(14).
Calculation of the estimated daily intake
The estimated daily intake (EDI) was calculated 
by the equation given by Bilandžić et al. (22), whereas 
the data for the mean detected concentrations for the 
analyzed residues and average daily consumption 
based on 60 kg body weight were taken into account. 
According to the literature data, the average daily 
milk consumption for an adult in Macedonia was 
200 mL (17,18).
RESULTS AND DISCUSSION
The objective of this study was to determine the 
residual levels of chloramphenicol as a prohibited 
substance, and tetracyclines, quinolones and 
sulfonamides throughout two and a half year of raw 
milk samples monitoring in Macedonia, to reveal if 
the maximum residue limits have been exceeded in 
terms of consumer health protection. 
All VMP residues analyses were performed using 
in-house validated screening methods according 
to the criteria laid down in Commission Decision 
2002/657/EC (14). Validation data corresponding 
to the screening method performance (LOD, LOQ, 
CCβ, recovery and precision) are presented in Table 
1. For all screening methods the obtained CCβ 
values were less than the ﬁ  xed MRLs or MRPL, with 
recoveries higher than 70 %. Moreover, the precision 
values were lower than the recommended maximal 
by the Horwitz equation (14). The validation data 
indicated that the applied methods were appropriate 
for the detection of residues of VMP measured.8
Table 1. Method validation data for the screening methods of the antibiotics analyzed in milk samples
Analyte
LOD LOQ CCβ Recovery Precision
(μg/kg) (μg/kg) (μg/kg) % %
Sulfonamides 13.5 45.0 64.5 97.5 4.5
Oxytetracycline 9.0 29.9 56.6 84.1 9.7
Tetracycline 13.8 46.1 53.8 80.4 10.5
Chlorotetracycline 16.7 55.7 58.4 99.1 7.1
Doxycycline 20.7 69.2 53.9 85.1 12.4
Quinolones
(Enroﬂ  oxacine)
4.2 10.8 58.6 78.3 16.2
Chloramphenicol <0.01 0.014 0.18 75.0 17.1
A total of 497 milk samples were subjected to the 
screening methods. The determined antimicrobial’s 
concentrations and MRLs for tetracyclines, 
quinolones and sulfonamides, as well as the MRPL 
value for chloramphenicol are summarized in Table 
2. All concentrations found for chloramphenicol 
were lower than the critical value established by 
Commission Decision 2003/181/EC (21). In the case 
of tetracyclines and sulfonamides a few samples 
were found exceeding the MRLs set by Commission 
Regulation (EU) 37/2010 (5). None of the samples 
examined contained residues of quinolones over the 
established MRL. In a previous study, residues of 
veterinary drugs were detected in total 4.3 % of milk 
samples collected in Macedonia during the 2010, 
using a screening diffusion test (Delvo test, DSM 
Food Specialities, Delft, The Netherlands) (19). 
The frequencies of detection of the individual 
antimicrobial substances (expressed in %) are 
presented on Figure 1. From the presented data 
it can be clearly concluded that in the raw milk 
samples the most frequently detected were the 
residues of tetracyclines (48.9 %). The occurrence 
of the individual substances was 32.7 %, 13.1 %, 
3.4 % and 2.5 % for oxytetracycline, tetracycline, 
chlortetracycline and doxycycline, respectively. 
Sulfonamides were detected in 18.4 % and 
quinolones in 6.8 % of the samples tested for 
residues of antimicrobial substances. 
Table 2. Veterinary drug residues (range and mean) in milk samples collected in the period from October 2008 until 
April 2011 and critical values regulated by EU and Macedonian legislation  
Analyte n
Range Mean MRL
(μg/kg) (μg/kg) (μg/kg)
Sulfonamides 497 13.5-147.9 4.71 100
Oxytetracycline 497 17.4-149.1 12.9 100
Tetracycline 497 19.7-80.5 4.6 100
Chlorotetracycline 497 13.6-63.9 0.9 100
Doxycycline 497 28.2-76.4 1.2 NE**
Total tetracyclines 497 13.6-149.1 19.6 100
Quinolones 497 0.6-22.0 12.5 100
Chloramphenicol* 497 0.002-0.074 0.019 0.3
* Chloramphenicol is not authorized for use in food producing animals in the European Union and in 
Macedonia (in MRL column the indicated value is MRPL)
**NE: not established; MRL value is not established for doxycycline, not authorized for milk producing 
animals in the European Union and in Macedonia
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Sulfonamides play important role as effective 
chemotherapeutics of bacterial and protozoan 
diseases and as growth promoters in veterinary 
medicine. The Committee for Veterinary Medicinal 
Products considers that the sum of all substances 
belonging to the sulfonamide group in raw milk 
should not exceed 100 μg/kg (23). During the past 
decades there have been reports on presence of 
sulfonamides in raw milk samples from Germany 
(24,25), whereas the prevalence for sulfonamides 
was 1,1 and 1,6 %. Other authors (26) have reported 
prevalence for total sulfonamides of 51,3 % and 
obtained concentration range from 1,9 to 180 μg/
kg. In the present study, the mean concentration 
of determined sulfonamides was approximately 21 
times lower than the established MRL. According 
to World Health Organization (WHO) (27) the 
acceptable daily intake (ADI) for sulfadimidine was 
established at 3 mg for 60 kg BW.
Tetracyclines are globally used as broad 
spectrum antibiotics in veterinary medicine against 
a wide range of Gram-positive and Gram-negative 
aerobics and anaerobic bacteria (28). Screening of 
Figure 1. Occurrence of individual antimicrobials or groups of antimicrobials (in %) regarding the LOD and CCβ 
values
*for chloramphenicol LOD value indicates the MRPL value
locally produced milk samples in Czech Republic 
indicates a presence of tetracyclines in 50,6 % of 
the analyzed samples with concentrations under the 
MRL value (29). In the present study, the highest 
tetracycline level detected has exceeded the MRL 
value and it was 149.1 μg/kg. However, the mean 
tetracycline concentration was more than ﬁ  ve times 
lower than the assigned MRL.
Quinolones are a group of relatively new 
antimicrobials synthesized from 3-quinolone 
carboxylic acid. They show excellent activity 
against both Gram-positive and Gram-negative 
organisms, as well anaerobes (30). Qunolones, 
especially enroﬂ  oxacine, are considered to be one 
of the most frequently applied MVP on the Belgian 
market. Despite this fact, during one investigation 
of the presence of these antimicrobials in 2008 
by E.coli test in microplate format, no quinolone 
residues were detected (31). In this study, the 
mean quinolones concentration (expressed as 
enroﬂ  oxacin) showed levels more than eight times 
below the established MRLs. 
Chloramphenicol is a broad spectrum antibiotic 
Mac. Vet. Rev. Vol 34, No. 1, 5 - 13, 201110
active against both Gram-positive and Gram-
negative bacteria and an effective therapeutic 
agent for the treatment of mastitis in cattle. Due 
to the potential risk to human health, the use of 
chloramphenicol is prohibited in food-producing 
animals in the European Union (5). The European 
Union introduced the concept of the minimum 
required performance limit (MRPL) of 0.3 μg/kg, the 
highest concentration level at which the screening 
and conﬁ   rmatory method shall demonstrate 
satisfactory performances regarding the sensitivity, 
accuracy and precision (21).
In this investigation, the measured 
chloramphenicol mean concentration of 19 ng/
kg was substantially lower than the MRPL value, 
and in practically it is the signal obtained from the 
blank. However, in the past decade there have been 
reports of incidences in other European countries 
for unauthorized presence of chloramphenicol: >0.2 
μg/kg in 2000 and 0.5 μg/kg in 2001 in Slovenia, 
0.72 μg/kg in 2006 in Poland, 0.3 μg/kg in 2002 in 
Lithuania, 0.14 μg/kg in 2004 in Estonia (32). The 
recent publications for presence of chloramphenicol 
residues found in 39 samples ranging from 0.3 to 
1.27 mg/kg has been reported in milk and dairy 
products mainly from Eastern European countries 
(33).
For the purpose of evaluation of dietary exposure 
with veterinary drugs residues through the intake of 
raw milk controlled in the present study, the (EDIs) 
for consumers were estimated. Table 3 shows the 
EDIs of veterinary drug residues based on the 
concentrations found in the present work, calculated 
with a presumed average daily milk consumption 
for an adult of 200 mL (15,16). Residue values 
of all MRL drugs measured, ranged from 0.033 
to 1.63 mg/kg BW/day, and were 2 to 100 times 
lower than the set values of ADIs (29, 34, 35). 
However, ADIs values have not been established 
for chloramphenicol. 
The highest individual calculation for EDI 
was obtained for oxytetracycline, which was 
approximately one half of the ADI value. The total 
EDI value obtained was 3.624 mg/kg BW/day, 
substantially lower than the total acceptable daily 
intake. Therefore, the toxicological risk associated 
with the consumption of analyzed milk could not be 
considered as a public health issue with regards to 
these veterinary antimicrobial substances.
Table 3. Estimation of daily intakes (EDIs) of veterinary drug residues through milk consumption based on the 
mean concentrations found in the period end of 2008 - beginning of 2011 
Analyte
EDI ADI
μg/kg BW/day μg/kg BW/day
Sulfonamides 0.177 50
Oxytetracycline 0.472 1
Tetracycline 0.169 1
Chlorotetracycline 0.033 1
Doxycycline 0.1 NE**
Total tetracyclines 1.63 3
Enroﬂ  oxacin 1.042 372
Chloramphenicol* 0.74* NE**
Total value 3.624 428
*EDI for chloramphenicol was expressed as ng/kg BW/day
**NE: Not yet have been established
CONCLUSION
The methods used for antibiotic determination 
in milk were validated according to Commission 
Decision 2002/657/EC and proved to be rapid, 
simple and reliable, exhibiting good accuracy and 
repeatability, with recovery higher than 70 %. In 
the two and a half year period of monitoring milk 
samples, the residues measured for quinolones were 
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far below the maximum residue limits (MRLs) set 
by the legislation. None of the samples exceeded 
the MRPL value for chloramphenicol. On the other 
hand, there have been a few samples containing 
amounts of sulfonamides and tetracyclines 
exceeding the established MRLs, that should be 
conﬁ  rmed by application of conﬁ  rmatory methods. 
The EDIs calculated showed that the contribution of 
milk to dietary intake of the investigated antibiotics 
were 2 to over 100 times below the ADIs proposed 
by EMEA and WHO. This indicates that the raw 
milk in Macedonia, in average, contains low levels 
of veterinary drugs, and therefore, it could be 
considered as safe for human consumption.
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